NOUBAR AFEYAN Insider Trading $MCRB Seres Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for NOUBAR AFEYAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of NOUBAR AFEYAN. NOUBAR AFEYAN is Director in AGENUS INC ($AGEN) and Director in BG Medicine, Inc. ($BGMD) and Director in Seres Therapeutics, Inc. ($MCRB) and Director in Moderna, Inc. ($MRNA) and Director in Evelo Biosciences, Inc. ($EVLO) and Director in Rubius Therapeutics, Inc. ($RUBY).
NOUBAR AFEYAN in Seres Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of NOUBAR AFEYAN: Director
Holdings: 4,444,444 shares
Current Value: $42,222,218
Latest Transaction: Jun 20 2019
$MCRB Market Capitalization: $374.90M
$MCRB Previous Close: $9.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of NOUBAR AFEYAN in Seres Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGEN, BGMD, EVLO, MRNA, RUBY, MCRB
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 20 2019 | MCRB | Seres Therapeutics ... | AFEYAN NOUBAR | Director | Buy | P | 2.25 | 4,444,444 | 9,999,999 | 4,444,444 | 0 to 4.4 M |
| Jun 20 2019 | MCRB | Seres Therapeutics ... | AFEYAN NOUBAR | Director | Buy | P | 2.25 | 4,444,444 | 9,999,999 | 4,444,444 | 0 to 4.4 M |
| Jun 14 2019 | MCRB | Seres Therapeutics ... | AFEYAN NOUBAR | Director | Option Exercise | A | 2.83 | 15,000 | 42,450 | 15,000 | |
| Jun 27 2018 | MCRB | Seres Therapeutics ... | AFEYAN NOUBAR | Director | Option Exercise | A | 9.09 | 15,000 | 136,350 | 15,000 | |
| Jun 27 2018 | MCRB | Seres Therapeutics ... | AFEYAN NOUBAR | Director | Option Exercise | A | 9.09 | 15,000 | 136,350 | 15,000 | |
| Jun 21 2017 | MCRB | Seres Therapeutics ... | AFEYAN NOUBAR | Director | Option Exercise | A | 11.21 | 15,000 | 168,150 | 15,000 | |
| May 27 2016 | MCRB | Seres Therapeutics ... | AFEYAN NOUBAR | Director | Sell | J | 0.00 | 33,514 | 0 | 0 | 33.5 K to 0 (-100.00 %) |
| May 27 2016 | MCRB | Seres Therapeutics ... | AFEYAN NOUBAR | Director | Buy | J | 0.00 | 7 | 0 | 33,514 | 33.5 K to 33.5 K (+0.02 %) |
| May 27 2016 | MCRB | Seres Therapeutics ... | AFEYAN NOUBAR | Director | Buy | J | 0.00 | 33,507 | 0 | 33,514 | 7 to 33.5 K (+478,671.43 %) |
| May 27 2016 | MCRB | Seres Therapeutics ... | AFEYAN NOUBAR | Director | Sell | J | 0.00 | 200,000 | 0 | 1,925,462 | 2.1 M to 1.9 M (-9.41 %) |
| May 27 2016 | MCRB | Seres Therapeutics ... | AFEYAN NOUBAR | Director | Sell | J | 0.00 | 800,000 | 0 | 8,022,420 | 8.8 M to 8 M (-9.07 %) |
| May 27 2016 | MCRB | Seres Therapeutics ... | AFEYAN NOUBAR | Director | Sell | S | 27.60 | 599,297 | 16,540,597 | 0 | 599.3 K to 0 (-100.00 %) |
| May 27 2016 | MCRB | Seres Therapeutics ... | AFEYAN NOUBAR | Director | Sell | S | 27.60 | 80,141 | 2,211,892 | 1,925,462 | 2 M to 1.9 M (-4.00 %) |
| May 27 2016 | MCRB | Seres Therapeutics ... | AFEYAN NOUBAR | Director | Sell | S | 27.60 | 320,562 | 8,847,511 | 2,734,994 | 3.1 M to 2.7 M (-10.49 %) |
| Jun 29 2015 | MCRB | Seres Therapeutics ... | AFEYAN NOUBAR | Director | Option Exercise | A | 18.00 | 15,000 | 270,000 | 15,000 | |
| Jun 29 2015 | MCRB | Seres Therapeutics ... | AFEYAN NOUBAR | Director | Option Exercise | C | 0.00 | 454,546 | 0 | 0 | |
| Jun 29 2015 | MCRB | Seres Therapeutics ... | AFEYAN NOUBAR | Director | Option Exercise | C | 0.00 | 1,818,181 | 0 | 0 | |
| Jun 29 2015 | MCRB | Seres Therapeutics ... | AFEYAN NOUBAR | Director | Option Exercise | C | 0.00 | 224,719 | 0 | 0 | |
| Jun 29 2015 | MCRB | Seres Therapeutics ... | AFEYAN NOUBAR | Director | Option Exercise | C | 0.00 | 898,877 | 0 | 0 | |
| Jun 29 2015 | MCRB | Seres Therapeutics ... | AFEYAN NOUBAR | Director | Option Exercise | C | 0.00 | 599,297 | 0 | 0 | |
| Jun 29 2015 | MCRB | Seres Therapeutics ... | AFEYAN NOUBAR | Director | Option Exercise | C | 0.00 | 1,526,338 | 0 | 0 | |
| Jun 29 2015 | MCRB | Seres Therapeutics ... | AFEYAN NOUBAR | Director | Option Exercise | C | 0.00 | 6,105,362 | 0 | 0 | |
| Jun 29 2015 | MCRB | Seres Therapeutics ... | AFEYAN NOUBAR | Director | Buy | C | 0.00 | 599,297 | 0 | 599,297 | 0 to 599.3 K |
| Jun 29 2015 | MCRB | Seres Therapeutics ... | AFEYAN NOUBAR | Director | Buy | C | 0.00 | 2,205,603 | 0 | 2,205,603 | 0 to 2.2 M |
| Jun 29 2015 | MCRB | Seres Therapeutics ... | AFEYAN NOUBAR | Director | Buy | C | 0.00 | 8,822,420 | 0 | 8,822,420 | 0 to 8.8 M |
Page: 1